Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…

New York, United States · Founded 2019 · $140.0M raised

Headquarters
New York, New York
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$140.0M
Last Round
$60.0M Series AMar 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Summary

Gilgamesh Pharmaceuticals is a Healthcare company based in New York, United States, founded in 2019. It has raised $140.0M in total across 4 rounds, most recently a $60.0M Series A round in Mar 2026. Investors include National Institute on Drug Abuse.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2026
$60.0M

Sign up to see all 4 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Hims and HersIPO

Telehealth platform providing personalized health and wellness treatments for men and women, cove...

San Francisco, United States501–1000Digital Health, E-Commerce
ConvertibleTotal funding$2.6BJan 2026
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
COMPASS PathwaysIPO

COMPASS Pathways is dedicated to accelerating patient access to evidence-based innovation in ment...

London, United Kingdom51–200Healthcare, Mental Health
Venture RoundTotal funding$997.0MFeb 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Gilgamesh Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/gilgamesh-pharma"><img src="https://indexed.vc/api/badge/company/gilgamesh-pharma" alt="Gilgamesh Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>